Abstract
This paper proposes a paradigm shift in medical treatment planning by framing the struggle against evolving diseases—such as cancer and HIV—as a multi-stage, incomplete-information game. By leveraging computational game theory and exploiting the inherent myopia of biological evolution, we can design strategic treatment sequences that steer diseases into "evolutionary traps." This framework moves beyond the current "myopic" medical approach, offering a formal methodology for long-term strategic intervention in biological systems.
Introduction
The fundamental challenge in treating many life-threatening diseases is resistance. Whether dealing with bacterial infections, viral loads like HIV, or heterogeneous cancer cell populations, these biological entities adapt to therapies with remarkable speed. Current medical treatment is often reactive and myopic, prescribing the drug that is most effective in the immediate term. However, this approach inadvertently mirrors the mechanism of evolution itself, which optimizes for immediate survival. This creates a cycle where short-term clinical successes drive the disease toward more dangerous, resistant states. To break this cycle, we require a formal, long-term strategic framework that accounts for the disease's inevitable counter-moves.
Modeling Treatment as an Extensive-Form Game
The core of this proposal is modeling medical treatment as a large-scale, incomplete-information, multi-stage game. In this model, the "Treater" (the clinician or algorithm) plays against the "Disease" (the evolving population). A third player, "Nature," is introduced to model stochasticity, such as randomness in diagnostic test results or the occurrence of specific mutations.
As shown in Figure 1, the interaction is represented as a game tree. Each node signifies a state (e.g., the current genetic makeup of a tumor), and edges represent actions, such as administering a specific drug, performing surgery, or a mutation event. Information sets (the shaded regions in Figure 1) represent the Treater's uncertainty about the exact state of the disease, reflecting the limitations of current diagnostic tools.
Exploiting Evolutionary Myopia
While game theory often focuses on finding a Nash Equilibrium—a "safe" strategy that assumes an optimal opponent—biological evolution has a systematic handicap: it is myopic. Evolution cannot look ahead in the game tree; it only reacts to current selective pressures.
Humans, however, possess the capacity for long-term planning. This asymmetry is the key to winning the game. By using opponent exploitation techniques, we can intentionally select treatments that might appear less effective in the short term but force the disease to evolve into an "evolutionary trap." These traps are states where the disease has zero resistance to a specific follow-up therapy, allowing for total eradication.
Computational Challenges and Implementation
Handling the astronomical number of possible genetic states in a biological system is computationally daunting. To make these models tractable, the paper suggests utilizing abstraction algorithms—similar to those used in high-level computer poker—to group similar game states together.
Building these models requires high-quality data from several sources:
- Scientific Databases: Information on mutation sites and drug-specific efficacy.
- SMART Trials: Sequential Multiple Assignment Randomized Trials that provide data on contingent treatment plans.
- Wet Lab Validation: The author suggests that these algorithmic strategies should be validated using inexpensive cancer cell lines to observe if evolution behaves as the game-theoretic models predict.
Conclusion
Just as AI has surpassed human intuition in complex games like Go and Poker, game-theoretic algorithms can generate sequential contingency plans far too complex for manual human design. This framework extends beyond clinical treatment to drug design and synthetic biology, providing a strategic advantage in steering biological evolution toward desired outcomes. The next critical step is the empirical validation of these "evolutionary traps" in controlled biological environments.
Summary updated